Skip to main content
Premium Trial:

Request an Annual Quote

Univ. of Arizona Expands SGI Altix Computer Cluster

NEW YORK (GenomeWeb News) – The University of Arizona has added an SGI Altix integrated computer environment, or ICE, system to its existing Altix shared memory system, SGI said today.
 
The university plans to make the new Altix ICE 8200, in addition to its Altix 4700 shared memory system, available to all research groups on campus, including life sciences researchers.
 
The school made the addition to its computing power under a program it began two years ago to replace its old shared memory computer with a larger shared memory computer and cluster computing system, according to Michael Bruck, who is assistant director of research computing at the University Information Technology Services of UA.
 
The ICE system has water-chilled racks that the school said will save energy and “greatly reduce” the electrical costs of its data center cooling, which SGI said is an emphasis in the school’s development plans.
 
Vicki Chandler, director of the school’s BIO5 Institute, will lead a group that will use the computer to study regulation of gene expression in maize, the company said.
 
Financial terms of the agreement were not released.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.